Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Cymbalta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cymbalta was produced by Lilly and Shionogi.

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Steven Paul, a veteran researcher who played a key role in developing Lilly’s antipsychotic and depression blockbuster drugs such as Zyprexa and Cymbalta is to head up efforts to find

Lilly mulls divestment of its animal health operations

Lilly mulls divestment of its animal health operations Alimta (pemetrexed) and antidepressant Cymbalta (duloxetine) resulting from generic competition.

Daiichi drug hits mark in shingles pain, but misses in other indications

Daiichi drug hits mark in shingles pain, but misses in other indications At the moment, there are just three approved drugs for fibromyalgia - Lyrica, Eli Lilly's Cymbalta (duloxetine) and Allergan's Savella (milnacipran) - and while these have been shown to reduce pain

Lilly’s president and chief executive John Lechleiter to retire

Lilly’s president and chief executive John Lechleiter to retire raloxifene) and antidepressant Cymbalta (duloxetine) have also expired.

UK court backs Actavis in dispute over Lilly's Alimta

UK court backs Actavis in dispute over Lilly's Alimta Maintaining Alimta's revenue stream is a priority for Lilly as it weathers the loss of patent protection for other brands, including osteoporosis drug Evista (raloxifene) and antidepressant Cymbalta (duloxetine) and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics